Compare ZTEK & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTEK | LNZA |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | Canada | United States |
| Employees | N/A | 192 |
| Industry | Major Chemicals | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 66.5M |
| IPO Year | 2022 | N/A |
| Metric | ZTEK | LNZA |
|---|---|---|
| Price | $0.57 | $5.24 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 138.8K | 80.3K |
| Earning Date | 02-18-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $55.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $0.24 |
| 52 Week High | $1.24 | $44.00 |
| Indicator | ZTEK | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 38.10 |
| Support Level | $0.55 | $5.02 |
| Resistance Level | $0.56 | $8.21 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 67.02 | 1.96 |
Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.